|
⚲
|
| Trinity Biosystems Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001186197 |
| Sale | 2009-05-15 ($12.5 M Offered, $7.5 M Sold) |
| Fund | |
| Phone | 6505660780 |
| Address | 1490 Obrien Avenue Menlo Park, 94025 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2026 |
|---|---|
| Rene Kuijten | |
| Michael Diem | |
| Amin Khan | |
| S Torres | |
| Peter McWilliams | |
| Gail Maderis | |
| Helen Kim |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Springstar Inc
✚
|
0.0 | |
|
Sammartino Investments LLC
✚
|
0.0 | |
|
Schechter Private Capital Fund I, LLC - Series G
✚
|
0.0 | |
|
Space Tango, Inc.
✚
|
0.0 | |
|
Strategic Value Restructuring ASP Fund A Series of ASP LLC
✚
|
0.0 | |
|
Universities Superannuation Scheme Ltd as sole corporate tru
✚
|
0.0 | |
|
Sprimo, Inc.
✚
|
0.0 | |
|
Stonepeak Infrastructure Fund III LP
✚
|
0.0 | |
|
Aquan LLC
✚
|
0.0 | |
|
Sexton Biotechnologies, Inc.
✚
|
0.0 |